Literature DB >> 18342645

The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth.

Bliss Kaneshiro1, Alison Edelman, Nichole Carlson, Mark Nichols, Jeffrey Jensen.   

Abstract

BACKGROUND: The study was conducted to characterize the relationship between body mass index (BMI) and unintended pregnancy, contraceptive use patterns, and perceived fertility.
METHODS: This study employed a cross-sectional, nationally representative database (2002 National Survey of Family Growth). Unintended pregnancy was compared among BMI groups [normal (<25 m/kg(2)), overweight (25-30 m/kg(2)) and obese (>30 m/kg(2))]. Analyses also evaluated the association between demographic, socioeconomic, behavioral and health-related variables and BMI. Multiple logistic regression with adjustment for sampling design was used to measure associations of interest.
RESULTS: BMI data were available from 6690 nonpregnant women. Of these, 3600 (53.6%) were normal weight, 1643 (25%) were overweight and 1447 (21.4%) were obese. Compared to women with normal BMIs, the risk of unintended pregnancy in the last 5 years did not differ among overweight [adjusted OR 0.95 (95% CI 0.77-1.17)] or obese [adjusted OR 0.87 (95% CI 0.70-1.09)] women. There were no differences in contraceptive use patterns or perceived fertility among BMI groups.
CONCLUSION: Data from the 2002 NSFG do not support an association between obesity and unintended pregnancy.

Entities:  

Mesh:

Year:  2008        PMID: 18342645     DOI: 10.1016/j.contraception.2007.10.012

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  11 in total

1.  Healthcare Provider Attitudes Regarding Contraception for Women with Obesity.

Authors:  Tara C Jatlaoui; Lauren B Zapata; Kathryn M Curtis; Suzanne G Folger; Polly A Marchbanks; Michele G Mandel; Denise J Jamieson
Journal:  J Womens Health (Larchmt)       Date:  2017-01-31       Impact factor: 2.681

Review 2.  Contraception and the obese woman.

Authors:  Elizabeth Reifsnider; Nonie Mendias; Yolanda Davila; Jennie Bever Babendure
Journal:  J Am Assoc Nurse Pract       Date:  2013-02-27       Impact factor: 1.165

3.  Class III obesity and unwanted pregnancy among women with live births in New York City, 2004-2007.

Authors:  Samantha Garbers; Mary Ann Chiasson
Journal:  Matern Child Health J       Date:  2013-10

Review 4.  Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review.

Authors:  Tara C Jatlaoui; Kathryn M Curtis
Journal:  Contraception       Date:  2016-05-24       Impact factor: 3.375

5.  Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.

Authors:  Hanna Xu; Jennifer A Wade; Jeffrey F Peipert; Qiuhong Zhao; Tessa Madden; Gina M Secura
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

6.  Contraceptive use by obese women 1 year postpartum.

Authors:  Jeanette R Chin; Geeta K Swamy; Truls Østbye; Lori A Bastian
Journal:  Contraception       Date:  2009-05-09       Impact factor: 3.375

7.  Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours.

Authors:  Nathalie Bajos; Kaye Wellings; Caroline Laborde; Caroline Moreau
Journal:  BMJ       Date:  2010-06-15

8.  Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity.

Authors:  Alison B Edelman; Nichole E Carlson; Ganesh Cherala; Myrna Y Munar; Richard L Stouffer; Judy L Cameron; Frank Z Stanczyk; Jeffrey T Jensen
Journal:  Contraception       Date:  2009-06-04       Impact factor: 3.375

Review 9.  Obesity and oral contraceptive pill failure.

Authors:  James Trussell; Eleanor Bimla Schwarz; Katherine Guthrie
Journal:  Contraception       Date:  2009-01-17       Impact factor: 3.375

10.  Family-planning practices among women with diabetes and overweight and obese women in the 2002 National Survey For Family Growth.

Authors:  Anjel Vahratian; Jennifer S Barber; Jean M Lawrence; Catherine Kim
Journal:  Diabetes Care       Date:  2009-03-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.